Anti-β(2)GPI/β(2)GPI induced TF and TNF-α expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways.
暂无分享,去创建一个
[1] S. Pierangeli,et al. Pathogenesis of the Antiphospholipid Syndrome , 2012, Seminars in Thrombosis & Hemostasis.
[2] K. McCrae,et al. A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies. , 2012, Blood.
[3] Hong Zhou,et al. Involvement of IRAKs and TRAFs in anti-β2GPI/β2GPI-induced tissue factor expression in THP-1 cells , 2011, Thrombosis and Haemostasis.
[4] E. Kruithof,et al. Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. , 2011, Blood.
[5] J. Musial,et al. Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state , 2011, Rheumatology International.
[6] H. Zhou,et al. Toll‐like receptor (TLR)‐4 mediates anti‐β2GPI/β2GPI‐induced tissue factor expression in THP‐1 cells , 2011, Clinical and experimental immunology.
[7] P. D. de Groot,et al. Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. , 2011, Blood.
[8] N. Tsuchimori,et al. TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules , 2011, Molecular Pharmacology.
[9] M. Khamashta,et al. Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future , 2010, European journal of clinical investigation.
[10] N. Mackman,et al. Role of tissue factor in thrombosis in antiphospholipid antibody syndrome , 2010, Lupus.
[11] M. Lorenz,et al. The Roll of Toll-like Receptors in the Antiphospholipid Syndrome , 2010, Current rheumatology reports.
[12] Hong Zhou,et al. Annexin A2 mediates anti-beta 2 GPI/beta 2 GPI-induced tissue factor expression on monocytes. , 2009, International journal of molecular medicine.
[13] Hong Zhou,et al. Annexin A2 mediates anti-β2GPI/β2GPI-induced tissue factor expression on monocytes , 2009 .
[14] K. Hajjar,et al. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. , 2009, Blood.
[15] N. Mackman,et al. Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies. , 2009, Blood.
[16] T. Kaisho,et al. Analysis of binding site for the novel small‐molecule TLR4 signal transduction inhibitor TAK‐242 and its therapeutic effect on mouse sepsis model , 2009, British journal of pharmacology.
[17] J. Brosens,et al. ORIGINAL ARTICLE: Antiphospholipid Antibodies Induce a Pro‐Inflammatory Response in First Trimester Trophoblast Via the TLR4/MyD88 Pathway , 2009, American journal of reproductive immunology.
[18] P. Meroni,et al. Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome , 2008, Lupus.
[19] C. Esmon. Reprint of Crosstalk between inflammation and thrombosis , 2008 .
[20] D. Tanné,et al. Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome , 2008, Neurobiology of Disease.
[21] T. Takano,et al. Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients. , 2008, Biochemical and biophysical research communications.
[22] G. Valesini,et al. Anti-β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts , 2007 .
[23] Xiaowei Liu,et al. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies , 2007, Annals of the rheumatic diseases.
[24] Y. Shoenfeld,et al. Infectious origin of the antiphospholipid syndrome , 2005, Annals of the rheumatic diseases.
[25] K. McCrae,et al. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. , 2005, Blood.
[26] Xiaoman Li,et al. The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. , 2004, Physiological genomics.
[27] A. Wolberg,et al. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. , 2004, Blood.
[28] A. Gharavi,et al. The molecular basis of antiphospholipid syndrome , 2003, Lupus.
[29] M. Lindsay,et al. Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[30] R. Parton,et al. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function , 1998, Nature.
[31] L. O’Neill,et al. Regulators of TLR4 signaling by endotoxins. , 2010, Sub-cellular biochemistry.
[32] Springer Basel Ag. Deciphering the complexity of Toll-like receptor signaling , 2010 .
[33] C. Esmon. Crosstalk between inflammation and thrombosis. , 2008, Maturitas.
[34] Chan Jun-mi,et al. International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome(APS) , 2008 .
[35] G. Valesini,et al. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. , 2007, Arthritis and rheumatism.
[36] Hong Zhou,et al. Involvement of annexin A2 in anti-beta2GPI/beta2GPI-induced tissue factor expression on monocytes. , 2007, Cell research.
[37] S. Strukova. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. , 2006, Frontiers in bioscience : a journal and virtual library.
[38] Strukova Sm. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. , 2006 .
[39] A. Chu. Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit. , 2006, Frontiers in bioscience : a journal and virtual library.
[40] Y. Shoenfeld,et al. Antiphospholipid Syndrome Infectious Origin , 2004, Journal of Clinical Immunology.